Biol. R. 1997; 61: 377-392 Xxxxx, X.X., Xxxxxxxx, P. and Xxxxx, X.X. Prospects of some essential oils as antifungal agents. J. Med. Arom. Plant Sci. 2000; 350-354 Xxxxxx, I.M.S., Xxxxxxxxx, X.X. and xxx Xxxxxx, X. Xxxxxxxxxxxxx, anti-inflammatory, anti- cholinesterase and mutagenic effects of extracts obtained from some trees used in South African traditional medicine. X. Xxxxxxxxxxxxxx. 2005; 102: 457-464 Fabricant, D.S. and Xxxxxxxxxx, X.X. The value of Plants Used in Traditional Medicine for Drug Discovery. Environ. Health Persp. 2001; 109: 69-75 Xxxxxx, M.R., Xxxx, X., Xxxxxx, M.M.A., Xxxxxxxx, X., Xxxxxxxxx, X. and Xxxxxx, N. Antimicrobial activities of Iranian sumac and avishan-e shirazi (Zataria multiflora) against some food-borne bacteria. Food Control 2007; 18: 646-649 Xxxxxx, X. Xxxxx for your Health. Interwave Press, Loveland, Colorado, USA, 1996: 56-57 Xxxxxxxx, M. Antibiotic activities of plant compounds against non-resistant and antibiotic resistant food borne human pathogens. In Xxxxxx, X.X., Xxxxxx, X.X., Xxxxxx, M.S. Advance in microbial food safety. American Chemical Soceity, Washington DC, USA, 2006: 167- 183 Xxxxxxxxx, X.X., Xxxxxx, D., Xxxxxxxxx, X.X. and Xxxxxxx, X. X. X. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 2000; 44: 2086-2092 Xxxxxxxx X. and Xxxxxxxx, T. Isolation and characterization of a protease from Bacteroides gingivalis. Infect Immun. 1987; 55: 716-720 In Xxxxx, X., Xxxxxx, P.T.M., Xxxxxxx, X.X., Xxxxxx, X. and Xxxxxxx, X.X. Antimicrobial actions of benzimidazoles against the oral anaerobes Fusobacterium nucleatum and Prevotella intermedia. Arch. Oral Biol. 2006; 51(11): 1015-1023 Xxxxxxxx, D., Xxx, S.E., Xxxxxxxx, X., Xxxxxxx, R., Xxxxxxx, X., Xxx, X.X. and Xxxx, M. Characterization of the Saccharomyces cerevisiae ERG27 gene encoding the 3- ketoreductase involved in C-4 sterol demethylation. Proc. Natl. Acad. Sci. USA 1999; 96: 12655-12660 Gafner, X., Xxxxxxxxx, X.X., Xxxxxx, M., Xxxxxxxx-Xxxxx, X. and Xxxxxxxxxxx, X. Xxxxxxxxxx and Antibacterial Naphthoquinones from Newbouldia laevis Roots. Phytochemistry 1996; 42: 1315-1320 Xxxxxx, X., Xxxxxx, X., Xxxxxxx, X. and Xxxxx, P. Chemical basis of the resistance of barley seeds to pathogenic fungi. Phytochemistry 1997; 44: 415-418 Xxxxxx, X., Xxxxxx, X., Xxxxxx, X. and Xxxxxxx, X. The effect of copper on the activity of cellulase and β-glucosidase in the presence of montmorillonite or A1-montmorillonite. ...

Biol. Xxxxxxxxx Xxxxxx prof. Xxxxx X'Xxxxxx (Yale University School of Medicine) Positive Scholarships (2023/2024) National Agency for Academic Exchange under the program "STER - Internationalization Doctoral Schools ”as part of the Internationalization Empowerment project Doctoral School of the Medical University of Lodz (InterEmpowereD) / Internationalization of the Doctoral School of the Medical University Łódź, co-financing agreement no .: BPI / STE / 2021/1/00032, Task 2 Payment NAWA scholarships for the best foreign and Polish doctoral students pursuing doctoral studies projects in international cooperation and aimed at obtaining a joint diploma or a double diploma. Scholarships in the amount of PLN 4000 monthly – for a period of 12 months. No. Surname and first name of the doctoral student Year The topic of the doctoral dissertation in accordance with IPB Department Supervisor Auxiliary promotor/ supervisor from the company - implementation doctorate Decision 1 XXXXXX SCHECANIAH XXXXXXXXXX I Comparison of nutritional assessment tools among elderly in the context of successful aging. Klinika Geriatrii prof. dr hab. n. med. Xxxxxx Xxxxxx dr n. med. Barłomiej Xxxxxxxx Positive

Biol. Macromol. 17: 395-404) However, the use of the other enzymes, like pectin lyase, xylanase or special cellulase in addition to the polygalacturonase, may increase the efficiency of the extraction process. For the present Project we can choose an industrial grade or ‘commercial pectinase’ with the concomitant ‘contaminants’ of xylanase and cellulase as the first option. As an alternative, we can also create the optimal enzyme cocktail through the addition of NRC-design cellulase and/or xylanase. The previous inventions involved an acidic degumming step with common acidic pectinase from acidophilic fungus Aspergillus niger, thereby causing the risk of potential acidic degradation of the cellulose fibers. As a parallel path in the middle stage of the Project, we’ll produce neutral or basic pectinase (preferably from neutral or alkalophilic bacteria) via gene cloning and expression, and the use of these ‘cloned neutral and basic pectinases’ may allow the degumming process at non-acidic pH. National Research Council Conseil national de recherches Terms for Canada Canada R&D Collaboration Goals & Deliverables NRC/IBS will be responsible for the following targets and deliverables:

Biol. CHEM. 258: 2808. 30 10. A method according to claim 9, 5. Xxxxxxx, H.D., Creek, K. E. and Sly, wherein said oligosac-charide fragment is W. S. (1982). J.

Related to Biol

Licensee Licensee represents and warrants that:
Sublicensee The term “
Licensor any Person from whom a Grantor obtains the right to use any Intellectual Property. Lien: any Person’s interest in Property securing an obligation owed to, or a claim by, such Person, whether such interest is based on common law, statute or contract, including liens, security interests, pledges, hypothecations, statutory trusts, reservations, exceptions, encroachments, easements, rights-of-way, covenants, conditions, restrictions, leases, and other title exceptions and encumbrances affecting Property. Lien Waiver: an agreement, in form and substance satisfactory to Collateral Agent, by which (a) for any material Collateral located on leased premises, the lessor waives or subordinates any Lien it may have on the Collateral, and agrees to permit Collateral Agent to enter upon the premises and remove the Collateral or to use the premises to store or dispose of the Collateral; (b) for any Collateral held by a warehouseman, processor, shipper, customs broker or freight forwarder, such Person waives or subordinates any Lien it may have on the Collateral, agrees to hold any Documents in its possession relating to the Collateral as agent for Collateral Agent, and agrees to deliver the Collateral to Collateral Agent upon request; (c) for any Collateral held by a repairman, mechanic or bailee, such Person acknowledges Collateral Agent’s Lien, waives or subordinates any Lien it may have on the Collateral, and agrees to deliver the Collateral to Collateral Agent upon request; and (d) for any Collateral subject to a Licensor’s Intellectual Property rights, the Licensor grants to Collateral Agent the right, vis-à-vis such Licensor, to enforce Collateral Agent’s Liens with respect to the Collateral, including the right to dispose of it with the benefit of the Intellectual Property, whether or not a default exists under any applicable License.
API If the Software offers integration capabilities via an API, your use of the API may be subject to additional costs or Sage specific policies and terms and conditions (which shall prevail in relation to your use of the API). You may not access or use the API in any way that could cause damage to us or the Software, or in contravention of any applicable laws. We reserve the right in our sole discretion, to: (i) update any API from time to time; (ii) place limitations around your use of any API; and (iii) deny you access to any API in the event of misuse by you or to otherwise protect our legitimate interests.
Baxter and Nexell shall cooperate in any action taken by a third party solely involving a nullity action, opposition, reexamination or any other action taken by such third party alleging the invalidity or unenforceability of any Licensed Intellectual Property. Both parties agree to share equally in the cost of the defense of such Licensed Intellectual Property.
Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.
Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.
Manufacturing License Subject to the terms of this Agreement, including without limitation Section 2.2, Theravance grants to GSK an exclusive license under the Theravance Patents and Theravance Know-How to make and have made API Compound or formulated Alliance Product in the Territory.
Sublicensees Licensee shall have the full right (but not the obligation) to sublicense those rights granted to it under Section 2.1 to a Third Party (a “Sublicensee”); provided, however, that, prior to the payment of the first milestone pursuant to Section 7.2, Licensee may not grant any such sublicense to any contract research organization conducting Clinical Trials of Products or any Third Parties conducting contract Manufacturing activities without Licensee’s prior written notice (at least twenty (20) Business Days in advance) to Lilly, which shall include a description of the rights to be granted and the purpose therefor, the identity of the Third Party and the countries involved, and Lilly’s prior written consent, but such consent shall only be required (i) until such time as Licensee is the holder of record for the Regulatory Materials related to Taladegib and (ii) to the extent such organization is not performing services for Licensee as of the Effective Date; and provided further, that Licensee shall remain responsible for the performance by any of its Sublicensees. With respect to any Sublicensee granted a sublicense to any Commercialization rights hereunder, Licensee shall ensure that each of its Sublicensees accepts in writing all applicable terms and conditions of this Agreement, including the non-compete, reporting, audit, inspection and confidentiality provisions hereunder. Each Sublicensee shall also be prohibited from further sublicensing. For the avoidance of doubt, (a) Licensee will remain directly responsible for all amounts owed to Lilly under this Agreement, and (b) each Sublicensee is subject to the negative and restrictive covenants set forth in Sections 2.3.1 and 2.5, respectively. Licensee hereby expressly waives any requirement that Lilly exhaust any right, power or remedy, or proceed against a subcontractor, for any obligation or performance hereunder prior to proceeding directly against Licensee.
Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

Biol Sample Clauses

Filter & Search

Related Clauses

Related to Biol